Citigroup’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$54.4M Buy
850,374
+202,060
+31% +$13.3M 0.02% 708
2026
Q1
$46.1M Buy
648,314
+19,391
+3% +$1.53M 0.02% 673
2025
Q4
$51.6M Buy
628,923
+36,000
+6% +$2.8M 0.02% 624
2025
Q3
$44.5M Sell
592,923
-268,154
-31% -$20M 0.02% 675
2025
Q2
$63.8M Buy
861,077
+10,061
+1% +$700K 0.03% 503
2025
Q1
$68.7M Sell
851,016
-12,841
-1% -$1.1M 0.04% 453
2024
Q4
$67.5M Sell
863,857
-6,824
-0.8% -$580K 0.04% 410
2024
Q3
$81.7M Buy
870,681
+150,273
+21% +$12.6M 0.05% 336
2024
Q2
$56.1M Buy
720,408
+349,502
+94% +$28.5M 0.04% 448
2024
Q1
$33.7M Buy
370,906
+115,682
+45% +$9.63M 0.02% 653
2023
Q4
$19.7M Buy
255,224
+23,007
+10% +$1.61M 0.01% 860
2023
Q3
$15.8M Sell
232,217
-17,069
-7% -$1.24M 0.01% 893
2023
Q2
$20.3M Buy
249,286
+107,093
+75% +$8.55M 0.01% 807
2023
Q1
$11.7M Buy
+142,193
New +$10.2M 0.01% 1085

Other funds holding GEHC

Citigroup's GEHC Position: Q2 2026 in Review

Citigroup increased its GE HealthCare (GEHC) stake by 31% in Q2 2026, buying an estimated $13.3M and bringing the position to 850,374 shares worth $54.4M. The position accounts for 0.02% of the portfolio, ranked #708.

Citigroup first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $81.7M in Q3 2024. 1,226 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Citigroup held 850,374 shares of GE HealthCare worth $54.4M as of Q2 2026.
  • Citigroup bought 202,060 GE HealthCare shares in Q2 2026, an estimated $13.3M.
  • GE HealthCare made up 0.02% of Citigroup's portfolio in Q2 2026, its #708 holding.
  • Citigroup first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Citigroup's GE HealthCare position peaked at $81.7M in Q3 2024.
  • 1,226 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.